Rodney H. Falk, MD
Dr. Rodney H. Falk is the Director of the Cardiac Amyloidosis Program and a cardiovascular medicine specialist at Brigham and Women’s Hospital (BWH). He is also an associate professor of medicine at Harvard Medical School.
Dr. Falk received his medical degree from the University of Birmingham Medical School in the United Kingdom. He then completed three residencies: an internal medicine program at Brook General Hospital, an internal medicine program at City Hospital and a cardiology program at King’s College Hospital, all in London. He also completed a cardiology fellowship at Harvard School of Public Health.
Dr. Falk is board certified in internal medicine and cardiovascular disease. He is the author of over 100 peer-reviewed publications, Dr. Falk’s research focuses on understanding cardiac amyloidosis and treatment of this rare disease. His research has been supported by the National Institutes of Health.
Dr. Falk’s speciality is cardiovascular medicine and his interests mainly include adult cardiology, anticoagulation, arrhythmias, cardiac amyloidosis, cardiac sarcoidosis, cardiomyopathy etc.
Representative Publications:
Early Detection of Multiorgan Light Chain (AL) Amyloidosis by Whole Body 18F-florbetapir PET/CT
Prognostic Significance of Strain Doppler Imaging in Light-Chain Amyloidosis
